Match Document Document Title
7605289 Benzamide derivatives and uses related thereto  
Benzamide derivatives of formula I and II, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof, and pharmaceutical compositions comprising the same, are described...
7592373 Amide compounds with MCH antagonistic activity and medicaments comprising these compounds  
Compounds of formula (I) wherein A, B, b, W, X, Y, Z, R 1 , R 2 , and R 3 have the meanings given in claim 1 , pharmaceutical compositions these compounds, and methods of preventing or...
7585856 Resolvins: Biotemplates for novel therapeutic interventions  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
7585517 Transscleral delivery  
Diseases associated with the tissues in the posterior segment of the eye can be effectively treated by administering therapeutic agents transsclerally to those tissues. Compositions, devices, and...
7572815 Amide derivative  
Amide derivatives represented by the formula (I): wherein: A is a cycloalkyl group, an aryl group or a heteroaryl group; X is a nitrogen atom or CR17; Y is —NRa—, —(CRbRb′)m-,...
7572814 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds  
Certain 3,5-dibenzoyl-4-phenyl-piperidine compounds and salts thereof are provided herein. The compounds and salts may be useful in causing mitotic arrest and cell death. Also provided herein are...
7572810 Alkene piperidine derivatives as antiviral agents  
This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with alkene piperidine...
7547731 Formamide derivatives for the treatment of diseases  
The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives....
7528170 Sulfonamide derivatives for the treatment of diseases  
The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives....
7517892 Ligands for monoamine receptors and transporters, and methods of use thereof  
One aspect of the present invention relates to heterocyclic compounds. A second aspect of the present invention relates to the use of the heterocyclic compounds as ligands for various mammalian...
7495105 Non-racemic mixtures of (S) and (R) enantiomers of N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; related processes and pharmaceutical compositions  
The present invention describes a method of separation of the enantiomers of N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide. Another object of the present invention refers to the...
7439257 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics  
The invention relates to a compound of formula (I): Wherein m, n, X, Y, R 1 , R 2 , R 3 and R 4 are as defined herein. The invention also relates to the use of same in therapeutics.
7425641 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions  
The present invention relates to carboxylic acid amides of general formula wherein R 1 to R 5 , Ar, m and n are defined as in claim 1 , the tautomers, stereoisomers, mixtures thereof,...
7378440 Substituted benzoylureido-o-benzoylamides, process for their preparation and their use  
The invention relates to substituted benzoylureido-o-benzoylamides and to their physiologically tolerated salts and physiologically functional derivatives. The invention relates to compounds of...
7375117 Polypeptides  
The present invention relates to polypeptides, and nucleic acids DNA encoding these polypeptides, capable of eliciting an immune reaction against cancer, methods for generating T lymphocytes...
7368443 2,6-disubstituted piperidines and piperazine compounds  
The present invention is directed to 2,6-disubstituted piperidine and piperazine analogs having the following general formula: which are used to treat diseases of the central nervous system,...
7361666 Heterocyclic analgesic compounds and methods of use thereof  
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various...
7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds  
The present invention relates to amide compounds of general formula I wherein the groups and residues A, B, b, W, X, Y, Z, R 1 , R 2 and R 3 have the meanings given in claim 1 . Moreover the...
7351702 Caspase inhibitors and uses thereof  
This invention provides compounds of formula I: wherein Z is oxygen or sulfur; R 1 is hydrogen, —CHN 2 , R, CH 2 OR, CH 2 SR, or —CH 2 Y; next to R 3 represents a single or double bond;...
7309714 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes  
The present invention is directed to phenylalanine derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or...
7294637 Method of treating addiction or dependence using a ligand for a monamine receptor or transporter  
One aspect of the present invention relates to a method of treating of drug addiction or drug dependence in a mammal, comprising the step of administering to a mammal in need thereof a...
7291620 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease  
The present invention is directed to compounds which are inhibitors of the beta-secretase enzyme and which are useful in the treatment or prevention of diseases in which the beta-secretase enzyme...
7291599 Use of inhibitors of enzymes having activities of amino peptidase N and/or dipeptidyl peptidase IV and of pharmaceutical preparations thereof for a therapy and prevention of chronical neurodegenerative diseases  
The invention relates to a process for the treatment of neurodegenerative diseases wherein mis-folded proteins accumulate in characteristic lesions and contribute substantially to a pathogenesis...
7268139 Methods of promoting osteogenesis  
The invention is directed to methods of bone healing by administering a p38 MAP kinase inhibitor. The invention is directed to methods of treating bone fractures, bone diseases, bone grafting,...
7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease  
The present invention relates to compounds of formula (I): useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme...
7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists  
Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.
7229969 Combinations of enzyme inhibitors and the use thereof  
Combination of inhibitors of dipeptidyl peptidase IV (DP IV) and enzymes having the same substrate specificity (DP IV-analogous enzymatic activity) and inhibitors of alanyl aminopeptidase...
7214714 20-hydroxyeicosatetraenoic acid production inhibitors  
A hydroxyformamidine compound represented by the following formula or a pharmaceutically acceptable salt thereof [wherein R 1 represents a substituted morpholino group, a substituted...
7202282 Microemulsions for selective molecular separation  
The subject invention provides microemulsions having, as one component thereof, electron-deficient aromatic rings, e.g.. di(trifluoromethyi) benzene, for efficient separation and/or isolation of...
7196103 Indole derivatives as factor Xa inhibitors  
The present invention is directed to the compound of formula I which is useful for inhibiting the activity of Factor Xa. The present invention is also directed to compositions containing said...
7173045 4-aminomethyl-1-aryl-cyclohexylamine compounds  
The invention concerns 4-aminomethyl-1-aryl-cyclohexylamine compounds, methods for producing same, pharmaceutical formulations containing said compounds and the use of...
7169797 Protein-tyrosine phosphatase inhibitors and uses thereof  
The present invention is directed to compounds of formula (I), or a pharmaceutically suitable salt or prodrug thereof, which are useful for the selective inhibition of protein tyrosine...
7153869 Substituted amino acids as erythropoietin mimetics  
This invention relates to a series of substitituted amino acids of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the...
7153866 Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia  
The present invention provides a method for the prophylactic and therapeutic treatment of cancer. The method comprises administering to an animal, preferably a mammal, more preferably a human, at...
7135483 Substituted heterocyclic compounds for treating multidrug resistance  
Substituted heterocyclinc compounds are disclosed. The compounds are useful for treating multidrug resistance. The compounds can be formulated in compositions with a carrier and, optionally, a...
7119105 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors  
The present invention relates to () non-peptide aspartyl protease inhibitors; (ii) methods for modulating the processing of an amyloid precursor protein (APP); (iii) methods for modulating the...
7109243 Inhibitors of cathepsin S  
The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at...
7109215 Compounds possessing neuronal activity  
The present invention relates to compounds, methods and pharmaceutical compositions for stimulating the growth of neurites in nerve cells. The compounds and the compositions and methods that...
7084144 Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction  
A compound having the general formula (I): wherein: X is N or C; R 0 is H, a lower alkyl group, a lower O-alkyl group, lower alkyl group, a benzyl group, a phenyl group, a heterocyclic...
7074820 Amidino derivatives and their use as thrombin inhibitors  
There is provided compounds of formula I, wherein R 1 , R 2 , R 3 , Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such...
7064124 NF-κB inhibitor containing substituted benzoic acid derivative as active ingredient  
A NF-κB inhibitor represented by the following formula (I) is provided:
7056935 Rotamase enzyme activity inhibitors  
This invention relates to methods of using neurotrophic compounds having an affinity for FKBP-type immunophilins to stimulate or promote neuronal growth or regeneration and to prevent neuronal...
7034043 Cell adhesion inhibitors  
A cell adhesion inhibitor of the general formula: R 3 -L-L′-R 1 is...
7030147 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative  
Epothilone derivatives are co-administered with an antidiarrheal agent, e.g., a DPP-IV inhibitor, in the treatment of a proliferative disease.
7030115 N-sulfonylurea apoptosis promoters  
Compounds having the formula are apoptosis promoters. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
7022687 Combination of loteprednol and antihistamines  
The present invention relates to a novel combination of a soft steroid, in particular loteprednol, and at least one antihistamine, such as, for example, azelastine and/or levocabastine, for...
7019003 Peptide deformylase inhibitors  
Novel PDF inhibitors and novel methods for their use are provided.
7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists  
Certain novel 4-substituted N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor...
7001915 Ultrashort-acting opioids for transdermal applications  
The subject invention encompasses compounds of the formula: wherein R 1 , R 2 , and R 3 are as defined herein. The subject invention also concerns methods for synthesizing the compounds of the...
6977264 Substituted piperidines and methods of use  
Selected substituted piperidine compounds are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and...